Involuntary Weight Loss Between Surgery and Chemotherapy Impairs Overall Survival of High-Grade Serous Ovarian Cancer Patients

Gynecologic Oncology - United States
doi 10.1016/j.ygyno.2016.04.269
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Predictors of Long-Term Survival Among High-Grade Serous Ovarian Cancer Patients

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2019English

New in High Grade Serous Ovarian Cancer Treatment

Effective Pharmacotherapy
2019English

Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer

JAMA Oncology
Cancer ResearchOncology
2017English

PARP Inhibitors in Platinum-Sensitive High-Grade Serous Ovarian Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2018English

Thrombocytosis and Hyperfibrinogenemia Are Predictive Factors of Clinical Outcomes in High-Grade Serous Ovarian Cancer Patients

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Low-Stage High-Grade Serous Ovarian Carcinomas

International Journal of Gynecological Pathology
GynecologyForensic MedicinePathologyObstetrics
2016English

Diffusion Kurtosis MRI as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy in High Grade Serous Ovarian Cancer

Scientific Reports
Multidisciplinary
2019English

Proteome Profiling of Low Grade Serous Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy